BACKGROUND: Increasing evidence links altered intestinal flora in infancy to eczema and asthma. No studies have investigated the influence of maternal intestinal flora on wheezing and eczema in early childhood. OBJECTIVE: To investigate the link between maternal intestinal flora during pregnancy and development of wheeze and eczema in infancy. METHODS: A total of 60 pregnant women from the Boston area gave stool samples during the third trimester of their pregnancy and answered questions during pregnancy about their own health, and about their children's health when the child was 2 and 6 months of age. Quantitative culture was performed on stool samples and measured in log(10)colony-forming units (CFU)/gram stool. Primary outcomes included infant wheeze and eczema in the first 6 months of life. Atopic wheeze, defined as wheeze and eczema, was analysed as a secondary outcome. RESULTS: In multivariate models adjusted for breastfeeding, day care attendance and maternal atopy, higher counts of maternal total aerobes (TA) and enterococci (E) were associated with increased risk of infant wheeze (TA: OR 2.32 for 1 log increase in CFU/g stool [95% CI 1.22, 4.42]; E: OR 1.57 [95% CI 1.06, 2.31]). No organisms were associated with either eczema or atopic wheeze. CONCLUSIONS AND CLINICAL RELEVANCE: In our cohort, higher maternal total aerobes and enterococci were related to increased risk of infant wheeze. Maternal intestinal flora may be an important environmental exposure in early immune system development.
BACKGROUND: Increasing evidence links altered intestinal flora in infancy to eczema and asthma. No studies have investigated the influence of maternal intestinal flora on wheezing and eczema in early childhood. OBJECTIVE: To investigate the link between maternal intestinal flora during pregnancy and development of wheeze and eczema in infancy. METHODS: A total of 60 pregnant women from the Boston area gave stool samples during the third trimester of their pregnancy and answered questions during pregnancy about their own health, and about their children's health when the child was 2 and 6 months of age. Quantitative culture was performed on stool samples and measured in log(10)colony-forming units (CFU)/gram stool. Primary outcomes included infant wheeze and eczema in the first 6 months of life. Atopic wheeze, defined as wheeze and eczema, was analysed as a secondary outcome. RESULTS: In multivariate models adjusted for breastfeeding, day care attendance and maternal atopy, higher counts of maternal total aerobes (TA) and enterococci (E) were associated with increased risk of infant wheeze (TA: OR 2.32 for 1 log increase in CFU/g stool [95% CI 1.22, 4.42]; E: OR 1.57 [95% CI 1.06, 2.31]). No organisms were associated with either eczema or atopic wheeze. CONCLUSIONS AND CLINICAL RELEVANCE: In our cohort, higher maternal total aerobes and enterococci were related to increased risk of infant wheeze. Maternal intestinal flora may be an important environmental exposure in early immune system development.
Authors: John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh Journal: Pediatrics Date: 2006-08 Impact factor: 7.124
Authors: Erick Forno; Andrew B Onderdonk; John McCracken; Augusto A Litonjua; Daniel Laskey; Mary L Delaney; Andrea M Dubois; Diane R Gold; Louise M Ryan; Scott T Weiss; Juan C Celedón Journal: Clin Mol Allergy Date: 2008-09-22
Authors: Ngoc P Ly; Begoña Ruiz-Pérez; Andrew B Onderdonk; Arthur O Tzianabos; Augusto A Litonjua; Catherine Liang; Daniel Laskey; Mary L Delaney; Andrea M DuBois; Hara Levy; Diane R Gold; Louise M Ryan; Scott T Weiss; Juan C Celedón Journal: Clin Mol Allergy Date: 2006-09-26
Authors: Daniela Börnigen; Xochitl C Morgan; Eric A Franzosa; Boyu Ren; Ramnik J Xavier; Wendy S Garrett; Curtis Huttenhower Journal: Genome Med Date: 2013-07-31 Impact factor: 11.117
Authors: Jason P Lynch; Md Al Amin Sikder; Bodie F Curren; Rhiannon B Werder; Jennifer Simpson; Páraic Ó Cuív; Paul G Dennis; Mark L Everard; Simon Phipps Journal: Front Immunol Date: 2017-02-16 Impact factor: 7.561
Authors: Lawrence E K Gray; Martin O'Hely; Sarath Ranganathan; Peter David Sly; Peter Vuillermin Journal: Front Immunol Date: 2017-03-31 Impact factor: 7.561